Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


New tricks for an old drug

The prodrug dimethyloxalylglycine (DMOG) is a well-known tool compound used to study hypoxia. New findings reveal that DMOG also inhibits glutamine metabolism and can be exploited to selectively kill some cancer cells, highlighting important caveats when using DMOG for hypoxia studies.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: DMOG metabolism and inhibitory activities.


  1. Semenza, G. L. Genes Dev. 14, 1983–1991 (2000).

    CAS  PubMed  Google Scholar 

  2. Cunliffe, C. J., Franklin, T. J., Hales, N. J. & Hill, G. B. J. Med. Chem. 35, 2652–2658 (1992).

    CAS  Article  Google Scholar 

  3. Majmundar, A. J., Wong, W. J. & Simon, M. C. Mol. Cell 40, 294–309 (2010).

    CAS  Article  Google Scholar 

  4. Pavlova, N. N. & Thompson, C. B. Cell Metab. 23, 27–47 (2016).

    CAS  Article  Google Scholar 

  5. Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J. & Schofield, C. J. Annu. Rev. Biochem. 87, 585–620 (2018).

    CAS  Article  Google Scholar 

  6. Louise Fets, P. C. D. et al. Nat. Chem. Biol. (2018).

  7. Lin, R. Y., Vera, J. C., Chaganti, R. S. & Golde, D. W. J. Biol. Chem. 273, 28959–28965 (1998).

    CAS  Article  Google Scholar 

  8. Maxwell, P. H. & Eckardt, K. U. Nat. Rev. Nephrol. 12, 157–168 (2016).

    CAS  Article  Google Scholar 

  9. Leung, I. K. et al. J. Med. Chem. 56, 547–555 (2013).

    CAS  Article  Google Scholar 

  10. Rendina, A. R. et al. Biochemistry 52, 4563–4577 (2013).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Costas A. Lyssiotis.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nelson, B.S., Kremer, D.M. & Lyssiotis, C.A. New tricks for an old drug. Nat Chem Biol 14, 990–991 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing